-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Exploring Time Off Treatment with a BCL-2 Inhibitor

Sponsor: AbbVie Oncology
Program: Product Theaters
Sunday, December 10, 2023: 8:00 AM-9:00 AM
Room 5B (San Diego Convention Center)
Jalaja Potluir, MD, AbbVie and Ahmed Kotb, MD, AbbVie
No relevant conflicts of interest to declare.
For In-Person Participants Only
See more of: Product Theaters